Please assess the completion status of the following clinical trial:

Trial Title: Combining LHu With Ultrasound Monitoring in IUI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Undergoing IUI treatments for:~  * Unexplained infertility (including endometriosis stage 1-2)~ * Mild male factor (\>5x106/ml motile sperm as determined by total sperm concentration x % A+B motility in the latest spermogram)~ * Donor insemination~* Natural or stimulated cycles with clomiphene citrate or letrozole~* At least 1 patent tube on hysterosalpingogram, hysterosonogram or laparoscopy within the last two years~* Antral follicular count ≥10 and FSH\<10~Exclusion Criteria:~* Polycystic ovarian syndrome or any cause of oligo or anovulation~* Patients taking other infertility medication (metformin, 17B estradiol, progesterone or gonadotropins)~* Presence of an ovarian cyst or a follicle \>20 mm on the first ultrasound or any reason for immediate HCG administration~* A previous sperm washing result with less than 5x106/ml motile sperm~* Previous inconclusive uLH test or inability to perform uLH testing

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 39 Years
- Healthy Volunteers: f

Study Arms:
- ultrasound alone group (Type: NO_INTERVENTION): Patients in the control group will have a standard ultrasound monitoring with HCG administered when the leading follicle reaches 18 mm, and IUI 36 h afterward.
- LH testing combined with ultrasound monitoring (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).